SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|
| BUSPAR 10MG TAB | 10 mg | Tablet · Oral use | 30 Blister | SAR 70.40 | NCE · Prescription | SPIMACO ADDWAEIH | Withdrawn by MAH · Not Marketed |
| BUSPAR 5MG TAB | 5 mg | Tablet · Oral use | 30 Blister | SAR 44.30 | NCE · Prescription | SPIMACO ADDWAEIH | Withdrawn by MAH · Not Marketed |
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|
| BUSPIRONE HYDROCHLORIDE | 5MG; 10MG; 15MG | tablet · oral | IMPAX LABS INC | Prescription | 28 Mar 2001 |
| BUSPIRONE HYDROCHLORIDE | 30MG; 5MG; 10MG; 15MG | tablet · oral | MYLAN | Prescription | 28 Jun 2001 |
| BUSPIRONE HYDROCHLORIDE | 5MG; 10MG; 15MG; 30MG | tablet · oral | TEVA | Prescription | 28 Feb 2002 |
| BUSPIRONE HYDROCHLORIDE | 5MG; 10MG; 15MG; 7.5MG; 30MG | tablet · oral | RISING | Prescription | 19 Mar 2002 |
| BUSPIRONE HYDROCHLORIDE | 5MG; 10MG; 15MG; 7.5MG; 30MG | tablet · oral | RUBICON RESEARCH | Prescription | 5 Apr 2002 |
| BUSPIRONE HYDROCHLORIDE | 5MG; 10MG; 15MG | tablet · oral | OXFORD PHARMS | Prescription | 9 May 2002 |
| BUSPIRONE HYDROCHLORIDE | 30MG | tablet · oral | OXFORD PHARMS | Prescription | 17 Dec 2007 |
| BUSPIRONE HYDROCHLORIDE | 5MG; 10MG; 15MG; 30MG; 7.5MG | tablet · oral | AUROBINDO PHARMA LTD | Prescription | 27 Feb 2009 |
| BUSPIRONE HYDROCHLORIDE | 5MG; 10MG; 15MG; 30MG; 7.5MG | tablet · oral | ZYDUS PHARMS | Prescription | 7 Feb 2014 |
| BUSPIRONE HYDROCHLORIDE | 5MG; 10MG; 15MG; 30MG; 7.5MG | tablet · oral | STRIDES PHARMA | Prescription | 25 Aug 2014 |
| BUSPIRONE HYDROCHLORIDE | 5MG; 7.5MG; 10MG; 15MG; 30MG | tablet · oral | ACCORD HLTHCARE | Prescription | 30 Dec 2014 |
| BUSPIRONE HYDROCHLORIDE | 5MG; 10MG; 15MG; 30MG | tablet · oral | HERITAGE PHARMA | Prescription | 18 Sep 2015 |
| BUSPIRONE HYDROCHLORIDE | 5MG; 10MG; 15MG; 30MG; 7.5MG | tablet · oral | AIPING PHARM INC | Prescription | 16 Dec 2015 |
| BUSPIRONE HYDROCHLORIDE | 5MG; 7.5MG; 10MG; 15MG; 30MG | tablet · oral | ADAPTIS | Prescription | 3 May 2018 |
| BUSPIRONE HYDROCHLORIDE | 5MG; 7.5MG; 10MG; 15MG; 30MG; 2.5MG; 12.5MG | tablet · oral | EPIC PHARMA LLC | Prescription | 16 Apr 2019 |
| BUSPIRONE HYDROCHLORIDE | 5MG; 10MG; 15MG; 30MG | tablet · oral | UNICHEM | Prescription | 14 Nov 2019 |
| BUCAPSOL | 7.5MG; 10MG; 15MG; 5MG | capsule · oral | EPIC PHARMA LLC | Prescription | 13 Mar 2025 |
| BUSPAR | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 30MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet · oral | BRISTOL MYERS SQUIBB | Discontinued | 29 Sep 1986 |
| BUSPAR | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | capsule · oral | BRISTOL MYERS SQUIBB | Discontinued | 20 Dec 2000 |
| BUSPIRONE HYDROCHLORIDE | 5MG; 7.5MG; 10MG; 15MG | tablet · oral | MYLAN | Discontinued | 28 Mar 2001 |
| BUSPIRONE HYDROCHLORIDE | 7.5MG | tablet · oral | MYLAN | Discontinued | 28 Jun 2001 |
| BUSPIRONE HYDROCHLORIDE | 5MG; 10MG; 15MG | tablet · oral | NESHER PHARMS | Discontinued | 27 Feb 2002 |
| BUSPIRONE HYDROCHLORIDE | 5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 10MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet · oral | IVAX SUB TEVA PHARMS | Discontinued | 1 Mar 2002 |
| BUSPIRONE HYDROCHLORIDE | 5MG; 10MG; 15MG | tablet · oral | EGIS | Discontinued | 14 Mar 2002 |
| BUSPIRONE HYDROCHLORIDE | 5MG; 7.5MG; 10MG; 15MG; 30MG | tablet · oral | AMNEAL PHARMS CO | Discontinued | 24 May 2017 |
Canada Canada — marketed products (Health Canada)
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|
| US NADAC | BUSPIRONE HCL 10 MG TABLET | $0.02795 | per EA | 30 Sep 2026 |
| US NADAC | BUSPIRONE HCL 15 MG TABLET | $0.04296 | per EA | 7 Oct 2026 |
| US NADAC | BUSPIRONE HCL 30 MG TABLET | $0.11985 | per EA | 23 Sep 2026 |
| US NADAC | BUSPIRONE HCL 5 MG TABLET | $0.02195 | per EA | 30 Sep 2026 |
| US NADAC | BUSPIRONE HCL 7.5 MG TABLET | $0.1003 | per EA | 30 Sep 2026 |
| NHS Drug Tariff | Buspirone 10mg tablets | £1.77 | 30 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Buspirone 15mg tablets | £23.33 | 30 tablet | 1 Oct 2026 |
| NHS Drug Tariff | Buspirone 5mg tablets | £1.41 | 30 tablet | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.